Shandong Boan Biotechnology Co., Ltd. (HKG:6955)
Hong Kong · Delayed Price · Currency is HKD 7.26
-0.02 (-0.27%)
At close: Apr 16, 2026
HKG:6955 Market Cap
HKG:6955 has a market cap or net worth of 4.52 billion as of April 16, 2026. Its market cap has decreased by -7.26% in one year.
Market Cap
4.52B
Enterprise Value
4.13B
Revenue
873.36M
Ranking
n/a
PE Ratio
568.33
Stock Price
7.26
Market Cap Chart
Since December 30, 2022, HKG:6955's market cap has decreased from 10.08B to 4.52B, a decrease of -55.19%. That is a compound annual growth rate of -21.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 4.52B | -14.99% |
| Dec 31, 2025 | 5.31B | 6.29% |
| Dec 31, 2024 | 5.00B | -36.66% |
| Dec 29, 2023 | 7.89B | -21.72% |
| Dec 30, 2022 | 10.08B | - |
| Dec 30, 2022 | 10.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jacobio Pharmaceuticals Group | 6.44B |
| Qyuns Therapeutics | 4.74B |
| Beijing Luzhu Biotechnology | 4.36B |
| TYK Medicines | 4.24B |
| Antengene Corporation | 4.18B |
| Viva Biotech Holdings | 4.05B |
| Clover Biopharmaceuticals | 3.79B |
| BioDlink International Company | 3.78B |